Sivik Global Healthcare’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.94M Hold
20,000
3% 11
2026
Q1
$3.94M Hold
20,000
3% 11
2025
Q4
$3.68M Buy
+20,000
New +$3.51M 1.07% 35
2025
Q2
Sell
-35,000
Closed -$5.14M 47
2025
Q1
$5.14M Buy
+35,000
New +$5.06M 2.78% 20
2020
Q3
Sell
-30,000
Closed -$9.21M 43
2020
Q2
$9.21M Sell
30,000
-7,500
-20% -$775K 3.05% 12
2020
Q1
$10.1M Sell
37,500
-25,000
-40% -$2.35M 4% 7
2019
Q4
$6.23M Buy
62,500
+22,500
+56% +$2.12M 2.31% 20
2019
Q3
$3.57M Sell
40,000
-10,000
-20% -$867K 1.8% 31
2019
Q2
$4.13M Sell
50,000
-25,000
-33% -$1.96M 1% 30
2019
Q1
$6.07M Buy
75,000
+7,300
+11% +$575K 2.23% 15
2018
Q4
$5.14M Buy
67,700
+5,200
+8% +$406K 2.77% 15
2018
Q3
$4.95M Sell
62,500
-12,500
-17% -$945K 1.77% 26
2018
Q2
$5.27M Buy
+75,000
New +$5.4M 2.03% 22
2017
Q2
Sell
-62,500
Closed -$3.89M 68
2017
Q1
$3.89M Sell
62,500
-72,500
-54% -$4.22M 1.81% 29
2016
Q4
$7.38M Buy
135,000
+35,000
+35% +$1.99M 3.52% 5
2016
Q3
$6.57M Buy
100,000
+45,000
+82% +$2.94M 3.31% 9
2016
Q2
$3.32M Buy
+55,000
New +$3.19M 1.65% 33

Other funds holding AZN

Sivik Global Healthcare's AZN Position: Q2 2026 in Review

Sivik Global Healthcare held its AstraZeneca (AZN) position steady in Q2 2026 at 20,000 shares worth $3.94M. The position accounts for 3% of the portfolio, ranked #11.

Sivik Global Healthcare first reported a position in AZN in Q2 2016 and has held it in 17 quarters since. The position peaked at $10.1M in Q1 2020. 588 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Sivik Global Healthcare held 20,000 shares of AstraZeneca worth $3.94M as of Q2 2026.
  • Sivik Global Healthcare left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 3% of Sivik Global Healthcare's portfolio in Q2 2026, its #11 holding.
  • Sivik Global Healthcare first reported a position in AstraZeneca in Q2 2016 and has held it in 17 quarters since.
  • Sivik Global Healthcare's AstraZeneca position peaked at $10.1M in Q1 2020.
  • 588 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Sivik Global Healthcare's 13F filing for Q2 2026, filed 20 Jul 2026.